Amicus Therapeutics to Announce Third Quarter 2017 Financial Results on November 8, 2017
October 25 2017 - 7:30AM
Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call
and live audio webcast on Wednesday, November 8, 2017 at 8:30 a.m.
ET to discuss financial results for the third quarter ended
September 30, 2017.
The call will be hosted by John F. Crowley,
Chairman and Chief Executive Officer. He will be joined on the call
by additional members of the Amicus management team. Interested
participants and investors may access the conference call by
dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international),
conference ID: 5995789.
A live audio webcast can also be accessed via
the Investors section of the Amicus Therapeutics corporate website
at http://ir.amicusrx.com/, and will be archived for 30 days. Web
participants are encouraged to go to the website 15 minutes prior
to the start of the call to register, download, and install any
necessary software.
A telephonic replay of the call will be
available for seven days beginning at 11:30 a.m. ET on November 8,
2017. Access numbers for this replay are 855-859-2056 (U.S./Canada)
and 404-537-3406 (international); conference ID: 5995789.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq:FOLD) is a global biotechnology company
at the forefront of therapies for rare and orphan diseases. The
Company has a robust pipeline of advanced therapies for a broad
range of human genetic diseases. Amicus’ lead programs in
development include the small molecule pharmacological chaperone
migalastat as a monotherapy for Fabry disease, as well as novel
enzyme replacement therapy (ERT) and biologic products for Fabry
disease, Pompe disease, and other rare and devastating
diseases.
CONTACTS:
Investors/Media:Amicus
TherapeuticsSara Pellegrino, IRCSenior Director, Investor
Relationsspellegrino@amicusrx.com (609) 662-5044
Media:W2O GroupJennifer
PaganelliMedia Relationsjpaganelli@purecommunications.com (347)
658-8290
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024